193 related articles for article (PubMed ID: 29066912)
1. Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis.
Singh AN; Sharma N
Onco Targets Ther; 2017; 10():4925-4933. PubMed ID: 29066912
[TBL] [Abstract][Full Text] [Related]
2. Identification of core differentially methylated genes in glioma.
Xue J; Gao HX; Sang W; Cui WL; Liu M; Zhao Y; Wang MB; Wang Q; Zhang W
Oncol Lett; 2019 Dec; 18(6):6033-6045. PubMed ID: 31788078
[TBL] [Abstract][Full Text] [Related]
3. Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics.
Wu K; Yin X; Jin Y; Liu F; Gao J
Cancer Cell Int; 2019; 19():51. PubMed ID: 30872976
[TBL] [Abstract][Full Text] [Related]
4. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer.
Tong Y; Song Y; Deng S
Cancer Cell Int; 2019; 19():50. PubMed ID: 30867653
[TBL] [Abstract][Full Text] [Related]
6. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers.
Liu Q; Reed M; Zhu H; Cheng Y; Almeida J; Fruhbeck G; Ribeiro R; Hu P
Genomics; 2022 Sep; 114(5):110474. PubMed ID: 36057424
[TBL] [Abstract][Full Text] [Related]
7. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
8. Identification of new differentially methylated genes that have potential functional consequences in prostate cancer.
Kim JW; Kim ST; Turner AR; Young T; Smith S; Liu W; Lindberg J; Egevad L; Gronberg H; Isaacs WB; Xu J
PLoS One; 2012; 7(10):e48455. PubMed ID: 23119026
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
11. Combined screening analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Cao J; Zhang R; Zhang Y; Wang Y
J Gastrointest Oncol; 2022 Feb; 13(1):311-325. PubMed ID: 35284134
[TBL] [Abstract][Full Text] [Related]
12. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
13. Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.
Huang CH; Han W; Wu YZ; Shen GL
Front Genet; 2022; 13():817656. PubMed ID: 35991567
[No Abstract] [Full Text] [Related]
14. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
[TBL] [Abstract][Full Text] [Related]
15. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
[TBL] [Abstract][Full Text] [Related]
18. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.
Xu Y; Tsai CW; Chang WS; Han Y; Huang M; Pettaway CA; Bau DT; Gu J
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944472
[TBL] [Abstract][Full Text] [Related]
19. Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer.
Guo L; Lin M; Cheng Z; Chen Y; Huang Y; Xu K
PeerJ; 2019; 7():e7899. PubMed ID: 31637138
[TBL] [Abstract][Full Text] [Related]
20. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
